key: cord-1025473-qynwfmsq
authors: Mann, Douglas L.
title: Warped Speed: How COVID-19 Transfected and Transformed Medical Journals
date: 2020-06-26
journal: JACC Basic Transl Sci
DOI: 10.1016/j.jacbts.2020.06.011
sha: 1446451effbe8754e310d9ef344fd62a8d8dd9cb
doc_id: 1025473
cord_uid: qynwfmsq

nan

"I feel the need-the need for speed" Peter "Maverick" Mitchell (fictional character in the movie "Top Gun")

The back-to-back announcements by the Lancet (1) and the New England Journal of Medicine (2) that they were retracting research papers on COVID-19 because of questions about the provenance of the data residing in a proprietary data base of electronic health care records administered by Surgisphere, a for profit healthcare analytics company, sent a series of seismic shocks and after-shocks rippling throughout the medical community. How could two of the most prestigious medical journals with highly qualified editorial boards with countless years of editorial experience publish articles whose validity was uncertain at best, and fictious at worst.

The answer(s) to the question of how and why this happened is likely multifactorial. As will be discussed in this Editor's page I believe that the retractions by the Lancet and the New England Journal of Medicine are symptomatic of subtle changes that have crept into the field of academic publishing over the past 60 years. I would like to begin by stating at the outset that none of my comments are intended to be critical of my colleagues who were directly or indirectly involved with these retractions, rather my comments are intended to shine a light on why retractions of this nature will continue to happen in the future unless we begin to understand the underpinnings of these mistakes.

Prior to emergence of medical journals in the 17 th Century, scientific meetings were the main way of communicating new scientific information (3) . The British Philosophical Transactions of the Royal Society of London, which was started by Henry Oldenburg in March 1665, remains the world's first and longest-running scientific journal. i The first edition of the Transactions (volume 1, issue 1) included articles with engaging titles such as "An account of a very odd monstrous calf" or a "A narrative concerning the success of pendulum-watches at sea for the longitudes" (4) . The advent of medical journals provided a new and exciting portal though which the scientific community could learn about the latest scientific developments monthly, rather than waiting for annual meetings. As newer scientific disciplines emerged, these communities began to publish articles that were better suited to their own interests. By the end of the 18th century several general medical journals were established, followed by the emergence of specialist medical journals at the beginning of the 20th century and subspecialty journals by the end of the 20 th century (3). These advances resulted in exponential growth in print scientific and medical journals, which plateaued in the 1990s, but were then followed by a veritable explosion in the growth in open access journals, which were not only able to publish articles online much faster than print journals, but also enjoyed profit margins that greatly exceeded those of print journals. Thus, what began in 1665 as means for disseminating new information to the scientific community, blossomed into a profitable business model that, like all businesses, had to compete for articles and readers in order to stay in business.

The need for speed. As journals evolved and expanded, journal editors recognized that in order to continue to flourish and maintain market share they needed to have a broader appeal to their readership that extended beyond publishing scientific articles, which led to journals to publish timely reviews and letters that informed the readership on the latest developments in their respective fields. Indeed, Sir Theodore ("Robbie") Fox, the prolific and transformative editor of the Lancet would often refer to the Lancet as a newspaper (3). Pari passu with the transition of journals from being a gateway for reporting the latest scientific articles to providing timely newsworthy content to their readers, in the 1990s journals also began to simultaneously publish articles on late breaking clinical trials that were being presented at national meetings. While the New England Journal has been always been particularly adept at attracting topline clinical trials presented at national meetings, it is important to note that all of the major journals adopted this practice in order to remain competitive within this specific journalistic space. As noted by Larry Husten, a veteran journalist who has covered cardiology news for decades, "simultaneous publication … brings a lot of benefits, including more rigorous peer review and superior and more widespread availability of trial results. Reducing the time between initial presentation and publication helps shorten the gap between the acquisition of new knowledge and its application to clinical practice." However, Husten also notes that simultaneous publication of clinical trials has "unintended consequences," including "the publication barrier seems to be far lower when a trial is published simultaneously at a major medical meeting." He also states that clinical trialists have confided to him that "compared to non-meeting related publications, the peer review process will be both less rigorous and less prolonged" (5) . Although hard data are lacking with respect to whether the peer review process is actually less rigorous for articles that are submitted for simultaneous publications, the editorial process surrounding late breaking clinical trials changed and became more streamlined, given the competing pressures imposed by the abbreviated time frames for peer review, for statistical review, for editorial oversight, and for generation of fully formatted articles that were available online at the time of the presentation at a meeting. While journals have been remarkably successful at accomplishing these tasks year after year, the need for speed in publishing changed the way in which the editorial process works, which laid the groundwork, at least in part, for the way for the way in which journals have faced the challenges imposed by COVD-19.

Warped speed. As the sheer magnitude of the COVID-19 pandemic began to become apparent, the pace of scientific publishing accelerated rapidly, dramatically compressing the time from months to weeks for performing experiments and submitting findings to journals, in an effort to mitigate the devastating consequences of the COVID-19 pandemic. Journals also had to scramble to handle the increased volume of submissions and to compress review and publication time frames by as much as 50% in order to provide timely information to the scientific community, with the hope that it might save lives. The World Health Organization described the onslaught of new information as an "infodemic -an over-abundance of information -some accurate and some not" (6). At some point, and it is hard to know when this occurred exactly, the need to balance scientific rigor against the need to rapidly disseminate new information tipped in favor of releasing information as fast as possible. Retraction Watch, a blog that reports on retractions of scientific papers, has reported that, at the time of this writing (6/21/2020), 20 COVID-19 papers had been retracted, 2 had been temporarily retracted, and 2 papers are been cited as containing misleading information (i.e., expressions of concern) (7). By the time this

Editor's Page appears in its final form, the number of COVID-19 retractions will almost assuredly have increased.

In a remarkably prescient article entitled "The trouble with medical journals," Dr. among the pubic-because publication and debate are fundamental values to both. In contrast, medical values, which put a strong emphasis on `doing no harm', might favour waiting until stronger evidence emerged (3) ." The COVID-19 pandemic has exposed and amplified many of the longstanding tensions that have existed with journals, dating back to 1665. Should journals favor scientific rigor over timeliness of reporting science that may change the response to a global crisis? In a perfect world journals should be able to accomplish both of these goals. In the imperfect world that we live in, in which the planet is facing a crisis brought about by a global pandemic that has crushing human and economic costs we cannot even begin to measure, let alone understand, it is perhaps inevitable that journals will get it wrong at times, in an earnest and honest effort to get it right for humanity. Going forward, we as a community need to acknowledge these shortcomings and learn from our mistakes, lest we repeat them. I suggest that that one salient guiding principal that should inform the way in which journal editors face the next crisis (COVID-20?) is to let their decisions be informed by one of the first lessons that I learned in medical school: primun non nocere.

Retracted .

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

The trouble with medical journals

Hot lines, simultaneous publications, and the decline of medical meetings CardioBrieforg: CardioBrief.org